Expert View: Wearable Technology And The FDA Adoption Curve
This article was originally published in Scrip
The US FDA recently announced that it will carefully consider the value of mobile technology in clinical research. By and large, the process of testing and approving new drugs and therapies has remained unchanged for the past 50 years. Today, data collected in everyday devices like smartphones and wearable fitness trackers could make clinical trials safer for patients and provide meaningful data to the FDA, write Barbara Elashoff and Glen de Vries of Medidata Solutions.
You may also be interested in...
The UK's Advertising Standards Authority will closely monitor the marketing communications of dietary supplements e-tailer Health Solutions after it failed to provide a substantive response to health claims regulation breaches.
Consensus report CR511 from the Association for the Advancement of Medical Instrumentation highlights common system elements for engineers, and outlines safety and risk-control measures that manufacturers and caregivers should consider.
The EU pharmaceutical strategy published on 25 November will be the first step in a “complete overhaul” of the medicines legislative framework to be proposed in about two years’ time, says the European Commission.